AAAAAA

   
Results: 1-19 |
Results: 19

Authors: PEREZ M PAUWELS PJ FOURRIER C CHOPIN P VALENTIN JP JOHN GW MARIEN M HALAZY S
Citation: M. Perez et al., DIMERIZATION OF SUMATRIPTAN AS AN EFFICIENT WAY TO DESIGN A POTENT, CENTRALLY AND ORALLY-ACTIVE 5-HT1B AGONIST, Bioorganic & medicinal chemistry letters, 8(6), 1998, pp. 675-680

Authors: JOHN GW VERSCHEURE Y INFANTI F BEL L PEREZ M HALAZY S CHOPIN P MARIEN M COLPAERT FC
Citation: Gw. John et al., IN-VIVO PHARMACOLOGICAL ACTIONS OF F-11356, A NOVEL HIGH EFFICACY ANTIMIGRAINE 5-HT1B D RECEPTOR AGONIST/, Naunyn-Schmiedeberg's archives of pharmacology, 358(1), 1998, pp. 5261-5261

Authors: COSI C MARIEN M
Citation: C. Cosi et M. Marien, DECREASES IN MOUSE-BRAIN NAD(-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE (MPTP) - PREVENTION BY THE POLY(ADP-RIBOSE) POLYMERASE INHIBITOR, BENZAMIDE() AND ATP INDUCED BY 1), Brain research, 809(1), 1998, pp. 58-67

Authors: JORANDLEBRUN C PAUWELS PJ PALMIER C CHOPIN P MORET C MARIEN M HALAZY S
Citation: C. Jorandlebrun et al., ARYLPIPERAZIDE DERIVATIVES OF PHENYLPIPERAZINES AS A NEW CLASS OF POTENT AND SELECTIVE 5-HT1B RECEPTOR ANTAGONISTS, Bioorganic & medicinal chemistry letters, 7(24), 1997, pp. 3183-3188

Authors: TELLEZ S COLPAERT F MARIEN M
Citation: S. Tellez et al., ACETYLCHOLINE-RELEASE IN THE RAT PREFRONTAL CORTEX IN-VIVO - MODULATION BY ALPHA(2)-ADRENOCEPTOR AGONISTS AND ANTAGONISTS, Journal of neurochemistry, 68(2), 1997, pp. 778-785

Authors: JORANDLEBRUN C PAUWELS PJ PALMIER C MORET C CHOPIN P PEREZ M MARIEN M HALAZY S
Citation: C. Jorandlebrun et al., 5-HT1B RECEPTOR ANTAGONIST PROPERTIES OF NOVEL ARYLPIPERAZIDE DERIVATIVES OF 1-NAPHTHYLPIPERAZINE, Journal of medicinal chemistry, 40(24), 1997, pp. 3974-3978

Authors: MARIEN M
Citation: M. Marien, TOP 10 REASONS THE INFORMATION REVOLUTION IS BAD FOR US, The Futurist, 31(1), 1997, pp. 11-12

Authors: MORET C MARIEN M
Citation: C. Moret et M. Marien, IN-VIVO AND IN-VITRO CHARACTERIZATION OF RELEASE-REGULATING 5-HT AUTORECEPTORS IN THE GUINEA-PIG RAPHE NUCLEUS AND HYPOTHALAMUS, British Journal of Pharmacology, 122, 1997, pp. 210-210

Authors: MARIEN M
Citation: M. Marien, NEW COMMUNICATIONS TECHNOLOGY - A SURVEY OF IMPACTS AND ISSUES, Telecommunications policy, 20(5), 1996, pp. 375-387

Authors: MARIEN M
Citation: M. Marien, THE FRAGMENTED FUTURES OF HUMAN-RIGHTS AND DEMOCRACY - A REVIEW OF RECENT LITERATURE, Futures, 28(1), 1996, pp. 51-73

Authors: COSI C CHOPIN P MARIEN M
Citation: C. Cosi et al., BENZAMIDE, AN INHIBITOR OF POLY(ADP-RIBOSE) POLYMERASE, ATTENUATES METHAMPHETAMINE-INDUCED DOPAMINE NEUROTOXICITY IN THE C57B1 6N MOUSE/, Brain research, 735(2), 1996, pp. 343-348

Authors: COSI C COLPAERT F KOEK W DEGRYSE A MARIEN M
Citation: C. Cosi et al., POLY(ADP-RIBOSE) POLYMERASE INHIBITORS PROTECT AGAINST MPTP-INDUCED DEPLETIONS OF STRIATAL DOPAMINE AND CORTICAL NORADRENALINE IN C57B1 6 MICE/, Brain research, 729(2), 1996, pp. 264-269

Authors: MARIEN M
Citation: M. Marien, WORLD FUTURES AND THE UNITED-NATIONS - A GUIDE TO RECENT LITERATURE, Futures, 27(3), 1995, pp. 287-310

Authors: TELLEZ S COLPAERT F MARIEN M
Citation: S. Tellez et al., THE ALPHA(2)-ADRENOCEPTOR ANTAGONIST, (-EFAROXAN, ENHANCES ACETYLCHOLINE-RELEASE IN THE RAT CORTEX IN-VIVO()), European journal of pharmacology, 277(1), 1995, pp. 113-116

Authors: MARIEN M
Citation: M. Marien, VISIONS OF SUSTAINABILITY, Futures, 26(2), 1994, pp. 115-116

Authors: MARIEN M
Citation: M. Marien, INFOGLUT AND COMPETING PROBLEMS - KEY BARRIERS SUGGESTING A NEW STRATEGY FOR SUSTAINABILITY, Futures, 26(2), 1994, pp. 246-256

Authors: CHERRUAU B NGUYENDAI D CALMUS Y DANGVU B MARIEN M HOUSSIN D
Citation: B. Cherruau et al., SERUM DELTA-BILIRUBIN CONJUGATED BILIRUBINS RATIO MEASUREMENT AS A LIVER-FUNCTION MARKER AFTER LIVER-TRANSPLANTATION, Gastroenterologie clinique et biologique, 17(5), 1993, pp. 370-375

Authors: MARIEN M
Citation: M. Marien, CULTURAL TRENDS, TROUBLES AND TRANSFORMATIONS - A GUIDE TO RECENT LITERATURE, Futures, 25(4), 1993, pp. 414-430

Authors: MARIEN M BRILEY M COLPAERT F
Citation: M. Marien et al., NORADRENALINE DEPLETION EXACERBATES MPTP-INDUCED STRIATAL DOPAMINE LOSS IN MICE, European journal of pharmacology, 236(3), 1993, pp. 487-489
Risultati: 1-19 |